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Abstract
Given that young women with breast cancer often have concerns and priorities attributable to
their life stage, we conducted a series of interviews to better understanding the surgical
decision-making experience among women diagnosed at age ≤40. Women spoke of how the
potential effect of an extended recovery was affecting their decision and, in some cases,
contributing to decisional conflict. Several women described their worry of leaving cancer cells
behind; others cited the need for continued surveillance as a consideration. Attention to
situational anxiety and concerns about recurrence is warranted to ensure decisions are made in
a supportive and patient-centered setting.
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Introduction
In the United States, more than 12,000 women under the age of 40 are diagnosed with
breast cancer each year (1). While treatment decisions for breast cancer patients of all ages are
affected by multiple factors, young women with breast cancer often have concerns and priorities
accentuated by their life stage (e.g., fertility, impact on a young family, starting a career, body
image) that may influence their surgical treatment considerations differently than older women.
With more young women with unilateral breast cancer choosing to have contralateral
prophylactic mastectomies (CPM), there has been increased attention to this trend. A recent
analysis of a nationally representative sample of over 1 million women reporting that the
percentage of women who had CPM nearly tripled between 2004 (10.5%) and 2012 (33.3%)(2).
CPM decreases the risk of developing a contralateral breast cancer, however for the majority of
women (e.g., those without a cancer pre-disposing mutation, such as BRCA1 or BRCA2) this 5year risk is estimated to be 2-3%(3-5). Additionally, the risk of distant recurrence is the same no
matter what breast cancer surgical procedure is chosen, with breast conserving surgery and
mastectomy (including CPM) conferring equivalent survival outcomes (6, 7).
Given recent surgical trends in young women with breast cancer, we conducted a series
of key informant interviews to gain an in-depth understanding of how newly-diagnosed young
women approached decisions about breast cancer surgery.

Methods
Between February and October 2016, we screened Dana-Farber Cancer Institute (DFCI)
clinic lists and approached newly-diagnosed women with non-metastatic (Stage 0-III) breast
cancer diagnosed at age 40 and younger who had not yet undergone surgery and invited them
to participate in a one-time interview study. Interested women who were eligible were
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interviewed either in person or via phone. After obtaining informed consent (written for inperson, verbal for phone), interviews were conducted in English except for a single interview
conducted in Spanish with the aid of a DFCI institutional interpreter.
A semi-structured interview script (see Appendix) was developed to explore different
aspects of the surgical decision-making process. Topics included: sources of information about
surgical options, pros and cons of each option, struggles with the surgical decision, physician
recommendations, expectations around recovery, genetic testing, and sources of assistance
with the decision process. In addition, women were asked for socio-demographic information,
clinical stage of disease (if known), and a single question about their preferred medical decisionmaking style (8). Interviews were expected to take approximately 20 minutes. Participants
received a $25 gift card in appreciation of their time. Interviews were recorded and transcribed
with identifiers removed. Following the creation of a preliminary codebook, transcripts were
coded by two researchers (SR and MG) using Nvivo software v11 (QSR International,
Burlington, MA). Initial codes were classified into preliminary themes and grouped in larger
domains using thematic content analysis. Preliminary themes related to the created domain,
“factors affecting the surgical decision process,” were subsequently re-classified under broader
themes and are presented here. Transcripts also were reviewed for information related to the
sources of information and support utilized, and the women’s stage of the decision process at
the time of the interview, including whether a participant indicated they had or had not yet made
a decision and choice of surgery (if the decision had been made). This research study was
approved by the DFCI Institutional Review Board.

Results
Among 20 participants, 20% (4/20) identified as Hispanic or non-White; almost all
(18/20) were partnered; median age at interview was 37 (Table 1). At the time of the interview,
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50% (10/20) of women reported knowing their clinical stage, with most having Stage 1 or 2
disease (9/10, 90%). A shared decision-making process around surgery was preferred by 45%
(9/20) of women; one participant preferred to make the decision about surgical treatment on her
own, while 40% (8/20) indicated they preferred making the decision on their own while seriously
considering their doctor’s opinion.
At the time interview, 60% (12/20) of women indicated they had made a decision about
surgery; of these 12, four women said their plan would change if their genetic testing came back
positive (Table 2). Among women who had not yet made a decision (n=8), two were leaning
towards mastectomy, two were undecided with no preference indicated, and four were waiting
for results of their genetic tests before deciding.
Analyses identified six primary themes: 1) post-surgical and survivorship concerns; 2)
emotional factors 3) local therapy concerns; 4) reconstruction; 5) recommendations about
surgery from providers, family, and friends; 6) family history and genetics. Themes and
corresponding sub-themes are presented in Table 3 together with illustrative quotes.
Post-surgical and survivorship concerns:
Future ability to breast feed was a factor for some women in the decision process.
Several women cited concerns about how an extended recovery would affect caring for young
children and returning to work, and in some cases, contributed to decisional conflict. For
example, one woman spoke of how the hardest thing she struggled with regarding her decision
was “…trying not to be over reactive in the moment when the decision I make is long-term.” In
weighing the pros and cons of different types of surgery, one participant spoke of wanting to
“choose the easiest, less invasive…that would be the fastest for me to be able to be back to my
children” while also acknowledging that a lumpectomy “doesn’t feel like… sufficient surgery.”
Another described how she “worried initially…about the recovery time with the double
mastectomy because I do have young kids so that was…daunting.”
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Emotional factors/ local therapy concerns/reconstruction:
The need for peace of mind and concerns about recurrence and contralateral breast
cancer also were cited by some women as affecting their decision. Several women spoke of
their worry that cancer cells would be left behind after surgery while others cited the need for
continued surveillance. Anxiety surrounding frequent mammograms and lack of trust in imaging
was also a consideration during the decision process. While issues related to appearance and
image were cited as considerations for many women, for others it was not a factor. One woman
articulated that she was “not concerned if I’m gonna look ugly…the only concern is my health.
But if they give me the opportunity to have reconstructive surgery, of course, I will do it.”
Recommendations from providers, family and friends:
Women shared that they received advice or recommendations from a range of sources,
including from providers, friends, and family members. One woman described feeling “pressure
from my husband to go the lumpectomy route” while another acknowledged “my husband wants
me to do them both…I’m just not sure what I want.” Women cited doctors and other providers as
being primary sources of information regarding surgical treatment options while partners, other
women with breast cancer, and family, friends, and colleagues were identified as being
common sources of support or information following diagnosis and during the decision process
(Table 2).
Family history and genetics
At the time of the interview, some women had already undergone genetic testing and knew their
results while others did not yet know their results or had not yet been tested. For many women,
knowing the results of their genetic testing – whether positive or negative – did influence
surgical decisions, especially whether or not to choose to have a contralateral prophylactic
mastectomy.
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Discussion
For young women with recently diagnosed early-stage breast cancer, practical concerns
are often weighed in combination with emotional factors when making decisions about surgical
treatment. As more young women have chosen to have bilateral mastectomies (6, 7),
understanding the implications of extensive surgery, including returning to work and childcare, is
essential during the decision-making process. Several young women brought up these concerns
when talking about the pros and cons of their surgical options, stressing the importance of these
issues. While concerns about the length and intensity of recovery following surgery were
reasons for some to consider less extensive surgery, apprehension around the future need for
surveillance, worry about recurrence, and peace of mind were reasons some women were
considering (and in some cases already had chosen) bilateral mastectomy. Anxiety and worry
about recurrence have been found previously to be associated with greater likelihood of
overestimation of breast cancer associated risks, including recurrence and contralateral breast
cancer, among both women with invasive breast cancer and ductal carcinoma in situ (DCIS) (911). Our group and others have previously reported that women cite decreasing their risk of
recurrence and contralateral breast cancer, and improving survival as reasons for choosing
mastectomy (12-16). The relationship between anxiety and inaccurate risk perceptions as well
as the evidence that these factors appear to affect decision-making further underscore the need
to account for the role of emotions during a time that can be particularly challenging given there
are other treatment-related decisions that are being made. For younger women, this can often
include decisions around fertility preservation as well.
Relative to older survivors, younger cancer survivors have been found to have more
concerns about recurrence (17), further highlighting the importance of attention to these issues
when young women are diagnosed with breast cancer and considering treatment options. While
almost half of the women interviewed noted a preference for shared decision-making, an equal
number said they preferred to make their surgical decision on their own, though most would
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consider their doctor’s opinion. These findings suggest that even among women who clearly
view the decision as their own, providers still play an influential role in the decision process. This
should include not only helping women understand the risks and benefits of different types of
breast cancer surgery but also addressing concerns about recurrence and anxiety that may be
hindering optimal decision-making.

Conclusion
This was a select population of women who were seen or treated at a comprehensive
cancer center and therefore generalizability may be limited. However, while findings from these
interviews may not reflect all experiences, they provide insights and add to the available
research examining the experiences of young women with breast cancer. In particular, these
findings highlight the tension between seemingly conflicting individual priorities and underscore
how surgical decisions can be complex for young women with breast cancer due to factors
specific to their life stage affecting decision-making.
Developing novel, targeted interventions that deliver relevant information and address
situational anxiety as well as concerns about recurrence, may reduce both decisional conflict
and distress. Specifically, breast cancer treatment decision aids have been shown to be
effective in increasing knowledge and decreasing decisional conflict and are generally wellreceived by patients (18-21). Additionally, these tools can assist providers with the
communication of the pros and cons of different surgical options, including the short and longerterm physical and emotional effects of surgery. One recently developed internet-based decision
aid for women thinking about CPM also included strategies to help manage concerns about
recurrence as well as concerns related to mammographic surveillance, which were two issues
that emerged in our study as affecting decisions (22). Given that concerns about recurrence and
cancer worry have been found to be associated with choosing CPM in prior studies(23, 24),
addressing anxiety around diagnosis and prognosis in the context of the decision process may
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help ensure surgical decisions are both informed and are made in a supportive and patientcentered setting.
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